作者
Parvarish Sharma, Meenu Mehta, Daljeet Singh Dhanjal, Simran Kaur, Gaurav Gupta, Harjeet Singh, Lakshmi Thangavelu, S Rajeshkumar, Murtaza Tambuwala, Hamid A Bakshi, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
发表日期
2019/8/25
来源
Chemico-biological interactions
卷号
309
页码范围
108720
出版商
Elsevier
简介
Cancer is one of the major diseases that cause a high number of deaths globally. Of the major types of cancers, lung cancer is known to be the most chronic form of cancer in the world. The conventional management of lung cancer includes different medical interventions like chemotherapy, surgical removal, and radiation therapy. However, this type of approach lacks specificity and also harms the adjacent normal cells. Lately, nanotechnology has emerged as a promising intervention in the management and treatment of lung cancers. Nanotechnology has revolutionized the existing modalities and focuses primarily on reducing toxicity and improving the bioavailability of anticancer drugs to the target tumor cells. Nanocarrier systems are being currently used extensively to exploit and to overcome the obstructions induced by cancers in the lungs. The nano-carrier-loaded therapeutic drug delivery methods have shown …
引用总数
2019202020212022202320249172271677755
学术搜索中的文章
P Sharma, M Mehta, DS Dhanjal, S Kaur, G Gupta… - Chemico-biological interactions, 2019